In fact, MLH1, MSH2, and EPCAM carriers are advised to initiate screening at age 20-25 or, if diagnosed before age 25, 2-5 years before the earliest diagnosis of CRC in the family, with intervals every 1-2 years (11–13). This evidence concerns the gene MLH1 and colorectal carcinoma.